Regulation of vascular L-type Ca2+ channels by phosphatidylinositol 3,4,5-trisphosphate

Circ Res. 2004 Aug 6;95(3):300-7. doi: 10.1161/01.RES.0000138017.76125.8b. Epub 2004 Jul 8.

Abstract

Modulation of voltage-gated L-type Ca2+ channels by phosphoinositide 3-kinase (PI3K) regulates Ca2+ entry and plays a crucial role in vascular excitation-contraction coupling. Angiotensin II (Ang II) activates Ca2+ entry by stimulating L-type Ca2+ channels through Gbeta-sensitive PI3K in portal vein myocytes. Moreover, PI3K and Ca2+ entry activation have been reported to be necessary for receptor tyrosine kinase-coupled and G protein-coupled receptor-induced DNA synthesis in vascular cells. We have previously shown that tyrosine kinase-regulated class Ia and G protein-regulated class Ib PI3Ks are able to modulate vascular L-type Ca2+ channels. PI3Ks display 2 enzymatic activities: a lipid-kinase activity leading to the formation of phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3 or PIP3] and a serine-kinase activity. Here we show that exogenous PIP3 applied into the cell through the patch pipette is able to reproduce the Ca2+ channel-stimulating effect of Ang II and PI3Ks. Moreover, the Ang II-induced PI3K-mediated stimulation of Ca2+ channel and the resulting increase in cytosolic Ca2+ concentration are blocked by the anti-PIP3 antibody. Mutants of PI3K transfected into vascular myocytes also revealed the essential role of the lipid-kinase activity of PI3K in Ang II-induced Ca2+ responses. These results suggest that PIP3 is necessary and sufficient to activate a Ca2+ influx in vascular myocytes stimulated by Ang II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Angiotensin II / pharmacology*
  • Animals
  • Barium / metabolism
  • Calcium / metabolism*
  • Calcium Channels, L-Type / drug effects*
  • Calcium Channels, L-Type / physiology
  • Calmodulin-Binding Proteins / pharmacology
  • Cells, Cultured / drug effects
  • Cells, Cultured / physiology
  • Class Ib Phosphatidylinositol 3-Kinase
  • Cytosol / metabolism
  • Dihydropyridines / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Ion Channel Gating / drug effects
  • Ion Transport / drug effects
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / genetics
  • Isoenzymes / physiology*
  • Lipid Metabolism
  • Membrane Potentials / drug effects
  • Muscle, Smooth, Vascular / cytology*
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / physiology
  • Nerve Tissue Proteins / pharmacology
  • Neurogranin
  • Patch-Clamp Techniques
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphatidylinositol Phosphates / antagonists & inhibitors
  • Phosphatidylinositol Phosphates / pharmacology*
  • Phosphatidylinositol Phosphates / physiology
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation / drug effects
  • Portal Vein
  • Protein Processing, Post-Translational / drug effects
  • Rats
  • Rats, Wistar
  • Recombinant Fusion Proteins / physiology
  • Substrate Specificity
  • Transfection
  • Wortmannin

Substances

  • Androstadienes
  • Calcium Channels, L-Type
  • Calmodulin-Binding Proteins
  • Dihydropyridines
  • Enzyme Inhibitors
  • Isoenzymes
  • Nerve Tissue Proteins
  • Nrgn protein, rat
  • Phosphatidylinositol Phosphates
  • Phosphoinositide-3 Kinase Inhibitors
  • Recombinant Fusion Proteins
  • phosphatidylinositol 3,4,5-triphosphate
  • Angiotensin II
  • Neurogranin
  • Barium
  • Class Ib Phosphatidylinositol 3-Kinase
  • Pik3cg protein, rat
  • oxodipine
  • Calcium
  • Wortmannin